BIOGEN INC (BIIB) Stock Balance Sheet
NASDAQ:BIIB - Nasdaq - US09062X1037 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.60B | 2.38B | 1.05B | 3.42B | 2.26B | |||
| Marketable Securities | N/A | N/A | 0.00 | 1.47B | 1.54B | |||
| Receivables | 2.00B | 1.87B | 2.10B | 2.14B | 1.96B | |||
| Inventories | 2.27B | 2.46B | 2.53B | 1.34B | 1.35B | |||
| Other Current Assets | 757.30M | 752.50M | 1.18B | 1.42B | 741.00M | |||
| Total Current Assets | 7.63B | 7.46B | 6.86B | 9.79B | 7.86B | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.48B | 3.54B | 3.73B | 3.70B | 3.79B | |||
| Investments And Advances | 559.10M | 560.50M | 745.00M | 2.23B | 2.83B | |||
| Goodwill | 6.48B | 6.48B | 6.22B | 5.75B | 5.76B | |||
| Intangibles | 9.58B | 9.69B | 8.36B | 1.85B | 2.22B | |||
| Other Non-Current Assets | 307.50M | 324.20M | 928.60M | 1.23B | 1.42B | |||
| Total Non-Current Assets | 20.41B | 20.59B | 19.99B | 14.76B | 16.02B | |||
| TOTAL ASSETS | 28.03B | 28.05B | 26.84B | 24.55B | 23.88B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.75B | 1.75B | 150.00M | 0.00 | 999.00M | |||
| Accrued Expenses | 1.32B | 1.59B | 1.66B | 1.59B | 1.47B | |||
| Accounts Payable | 391.50M | 424.20M | 403.30M | 492.00M | 589.00M | |||
| Other Current Liabilities | 1.83B | 1.77B | 1.22B | 1.19B | 1.24B | |||
| Total Current Liabilities | 5.30B | 5.53B | 3.43B | 3.27B | 4.30B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 4.55B | 4.55B | 6.79B | 6.28B | 6.27B | |||
| Deferred Taxes/Income | 133.20M | 190.50M | 641.80M | 335.00M | 695.00M | |||
| Other Non-Current Liabilities | 1.08B | 1.07B | 1.18B | 1.28B | 1.65B | |||
| Total Non-Current Liabilities | 5.76B | 5.80B | 8.61B | 7.88B | 8.68B | |||
| TOTAL LIABILITIES | 11.05B | 11.33B | 12.05B | 11.16B | 12.98B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 19.50B | 19.26B | 17.63B | 16.47B | 13.91B | |||
| Additional Paid In Capital | 629.90M | 569.40M | 302.50M | 73.00M | 68.00M | |||
| Minority Interest | N/A | 0.00 | 0.00 | -10.00M | 64.00M | |||
| Common Shares | 100.00K | 100.00K | 100.00K | 0.00 | 0.00 | |||
| Treasury Stock | -2.98B | -2.98B | -2.98B | -2.98B | -2.98B | |||
| Other Shareholders' Equity | -174.50M | -136.20M | -153.70M | -149.00M | -105.00M | |||
| Shares Outstanding | 146.50M | 145.70M | 144.90M | 144.00M | 147.00M | |||
| Tangible Book Value per Share | 6.26 | 3.75 | 1.50 | 40.27 | 19.82 | |||
| Total Shareholders' Equity | 16.98B | 16.72B | 14.80B | 13.40B | 10.90B | |||
| TOTAL LIABILITIES AND EQUITY | 28.03B | 28.05B | 26.84B | 24.55B | 23.88B | |||
| Statistics | ||||||||
| Debt/Equity | 0.27 | 0.27 | 0.46 | 0.47 | 0.58 | |||
| Current Ratio | 1.44 | 1.35 | 2.00 | 2.99 | 1.83 | |||
| Return On Assets (ROA) | 5.28% | 5.82% | 4.33% | 12.41% | 6.52% | |||
| Return On Equity (ROE) | 8.71% | 9.76% | 7.85% | 22.74% | 14.28% | |||
| Return On Invested Capital (ROIC) | 9.95% | 10.31% | 8.14% | 13.27% | 15.64% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 11.23% | 11.53% | 8.52% | 17.23% | 19.41% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 55.50% | 58.43% | 24.49% | 32.13% | 39.28% | |||
All data in USD , ROIC based on taxRate of 0.12